109 related articles for article (PubMed ID: 37962580)
1. Design of new Mcl-1 inhibitors for cancer using fragments hybridization, molecular docking, and molecular dynamics studies.
Alzain AA; Elbadwi FA; Mukhtar RM; Shoaib TH; Abdelmoniem N; Miski SF; Ghazawi KF; Alsulaimany M; Mohamed SGA; Ainousah BE; Hussein HGA; Mohamed GA; Ibrahim SRM
J Biomol Struct Dyn; 2023 Nov; ():1-13. PubMed ID: 37962580
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
3. Discovery of small molecule inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulation and experimental validation against myeloid cell leukemia-1 (Mcl-1).
Suleiman MR; Wang H; Huang D; Wang H; Joseph J; Huang T; Zhang F; Wang J; Cheng M
J Biomol Struct Dyn; 2021 Apr; 39(7):2512-2525. PubMed ID: 32228162
[TBL] [Abstract][Full Text] [Related]
4. De Novo Design of Cathepsin B1 Inhibitors as Potential Anti-Schistosomal Agents Using Computational Studies.
Alzain AA; Elbadwi FA
Adv Appl Bioinform Chem; 2022; 15():29-41. PubMed ID: 35935393
[TBL] [Abstract][Full Text] [Related]
5. In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer.
Ren JX; Li CP; Zhou XL; Cao XS; Xie Y
J Biomol Struct Dyn; 2018 Jul; 36(9):2424-2435. PubMed ID: 28714799
[TBL] [Abstract][Full Text] [Related]
6. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
[TBL] [Abstract][Full Text] [Related]
7. A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.
Liu W; Khalid M; Wahab S; Faizan Siddiqui M; Hasan Khan S; Sadiq M; Khatoon Z
J Biomol Struct Dyn; 2024 Jul; 42(10):5219-5228. PubMed ID: 37418235
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
9. Binding mode of Pyridoclax to myeloid cell leukemia-1 (Mcl-1) revealed by nuclear magnetic resonance spectroscopy, docking and molecular dynamics approaches.
Bourafai-Aziez A; Sebban M; Benabderrahmane M; Marekha B; Denis C; Paysant H; Weiswald LB; Carlier L; Bureau R; Coadou G; Ravault D; Voisin-Chiret AS; Sopková-de Oliveira Santos J; Oulyadi H
J Biomol Struct Dyn; 2020 Sep; 38(14):4162-4178. PubMed ID: 31612791
[TBL] [Abstract][Full Text] [Related]
10. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors.
Ouassaf M; Daoui O; Alam S; Elkhattabi S; Belaidi S; Chtita S
J Biomol Struct Dyn; 2023; 41(16):7712-7724. PubMed ID: 36106982
[TBL] [Abstract][Full Text] [Related]
13. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches.
Selvakumar R; Anantha Krishnan D; Ramakrishnan C; Velmurugan D; Gunasekaran K
J Biomol Struct Dyn; 2020 Feb; 38(3):682-696. PubMed ID: 30806580
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments.
Yue J; Li Y; Li F; Zhang P; Li Y; Xu J; Zhang Q; Zhang C; He X; Wang Y; Liu Z
Comput Biol Med; 2023 Jan; 152():106350. PubMed ID: 36493735
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches.
Babu S; Nagarajan SK; Sathish S; Negi VS; Sohn H; Madhavan T
Front Pharmacol; 2022; 13():837369. PubMed ID: 35529449
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
18. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3β) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis.
Benghanem S; Mesli F; Fatima Zohra HA; Nacereddine C; Hadjer C; Abdellatif M
J Biomol Struct Dyn; 2023 Jul; ():1-16. PubMed ID: 37498130
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the molecular mechanism of benzothiophene and benzofuran scaffold-merged compounds binding to anti-apoptotic Myeloid cell leukemia 1.
Marimuthu P; Singaravelu K
J Biomol Struct Dyn; 2019 May; 37(8):1992-2003. PubMed ID: 29745292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
